Ario Pharma Overview
- Founded
- 2009
- Status
- Out of Business
- Employees
- 3
- Latest Deal Type
- Out of Business
Ario Pharma General Information
Description
Developer of therapeutic drugs designed to treat neuropathic and inflammatory pain. The company's drugs include a series of small molecule TRPV1 antagonists that are clinical ready and safe, enabling patients to have access to drugs for the treatment of respiratory disease.
Contact Information
Website
www.ariopharma.com
Formerly Known As
Provesica
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Saint John's Innovation Centre
- Cowley Road
- Cambridge CB4 0WS
- England, United Kingdom
+44 01223 000000
Ario Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Oct-2019 | 000.00 | Completed | Out of Business | ||
| 3. Later Stage VC (Series A) | 12-Mar-2015 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 2. Later Stage VC (Series A) | 27-Feb-2014 | $3.39M | $9.7M | 000.00 | Completed | Generating Revenue |
| 1. Later Stage VC (Series A) | 16-Dec-2010 | $6.3M | $6.3M | 000.00 | Completed | Startup |
Ario Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Ario Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial